Improving sarcopenia by targeting mitochondria
通过靶向线粒体改善肌肉减少症
基本信息
- 批准号:10736713
- 负责人:
- 金额:$ 67.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-05 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:ATP Synthesis PathwayAdultAffectAgeAgingBaltimoreBiological MarkersBloodCardiolipinsCardiometabolic DiseaseCentral obesityClinical TrialsDataDevelopmentDietDietary intakeDouble-Blind MethodDyslipidemiasElderlyElectron TransportEssential Fatty AcidsEventExerciseExtensorExtravasationFDA approvedFatigueGait speedHealthHealth Care CostsHumanImmobilizationImpairmentInner mitochondrial membraneInsulin ResistanceIntakeIntramuscularIsotonic ExerciseLegLifestyle TherapyLinkLinoleic AcidsLongitudinal StudiesLysophosphatidylcholinesMammalsMeasuresMethodsMitochondriaMorbidity - disease rateMusMuscleMuscle WeaknessMuscle functionMuscular AtrophyNutritional RequirementsOilsOleic AcidsOmega-3 Fatty AcidsOutcomePathologicPatternPersonsPharmaceutical PreparationsPhasePhospholipidsPhysical FunctionPhysical activityPlacebosPlasmaPostmenopausePreventionProbabilityProductionProtonsRandomized, Controlled TrialsRecommendationReportingResistanceRespirationRiskRodent ModelRoleSideSkeletal MuscleSourceSpecific qualifier valueSupplementationTestingTherapeuticThinnessTissuesTriglyceridesVegetable OilsWomanage relatedcardiometabolismcomparison controldietarydietary approachdisorder riskepidemiologic datafall riskfortificationhealth dataimprovedinnovationlinoleateslong chain fatty acidmitochondrial dysfunctionmortalitymuscle formmuscle strengtholder menolder womenpeerphase II trialpreventprimary outcomeprotective effectprotein intakeresistance exercisesarcopeniascaffoldskeletal muscle wastingtargeted treatment
项目摘要
Sarcopenia, the age-related loss of skeletal muscle mass and function, predicts for morbidity, mortality and
excessive healthcare costs. Other than exercise, lifestyle therapies for slowing the progression of sarcopenia
in older men and women remain elusive. Mitochondrial dysfunction is a common mechanistic link between
aging and many pathological factors contributing to sarcopenia. We propose to test whether supplementing
the diet with an oil rich linoleic acid (LA; 18:2n6), the preferred fatty acyl constituent of cardiolipin, improves
muscle strength and physical mobility. In mice, dietary LA-rich oil increases LA-rich cardiolipin (e.g., 4-LA-
cardiolipin) and mitochondrial respiration. Therefore, the effect of LA-rich oil to increase 4-LA-cardiolipin and
mitochondrial respiration in older people with sarcopenia will be measured evaluated. Because LA is a
required nutrient for humans, e.g., an essential fatty acid that must be attained in the diet, dietary sources are
the sole method to replenish LA for cardiolipin, the signature phospholipid of inner mitochondrial membranes.
In a phase II double-blinded, randomized controlled trial, this study will test the effect of LA-oil supplementation
to change muscle strength, physical mobility, 4-LA-cardiolipin and mitochondrial function. Identifying a
mechanistic link between LA and mitochondrial capacity could aid in the development of mechanistically
targeted therapies to slow or stop the progression of sarcopenia as well as other mitochondrial-related
conditions that develop in older adults.
肌肉减少症,即与年龄相关的骨骼肌质量和功能丧失,可预测发病率、死亡率和
过高的医疗费用。除了运动之外,生活方式疗法也可以减缓肌肉减少症的进展
在老年男性和女性中仍然难以捉摸。线粒体功能障碍是线粒体之间的常见机制联系
衰老和许多导致肌肉减少症的病理因素。我们建议测试是否补充
富含油的亚油酸(LA;18:2n6)(心磷脂的首选脂肪酰基成分)的饮食可以改善
肌肉力量和身体活动能力。在小鼠中,饮食中富含 LA 的油会增加富含 LA 的心磷脂(例如 4-LA-
心磷脂)和线粒体呼吸。因此,富含LA的油具有增加4-LA-心磷脂和
将测量评估患有肌肉减少症的老年人的线粒体呼吸。因为洛杉矶是一个
人类所需的营养素,例如必须从饮食中获得的必需脂肪酸,饮食来源是
补充 LA 心磷脂(线粒体内膜的标志性磷脂)的唯一方法。
在一项 II 期双盲、随机对照试验中,本研究将测试补充 LA 油的效果
改变肌肉力量、身体活动能力、4-LA-心磷脂和线粒体功能。识别一个
LA 和线粒体能力之间的机制联系可能有助于机制的发展
减缓或阻止肌肉减少症以及其他线粒体相关疾病进展的靶向治疗
老年人出现的病症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARTHA A BELURY其他文献
MARTHA A BELURY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARTHA A BELURY', 18)}}的其他基金
Dietary fats, mitochondrial function and muscle health in cancer patients
癌症患者的膳食脂肪、线粒体功能和肌肉健康
- 批准号:
9456294 - 财政年份:2018
- 资助金额:
$ 67.88万 - 项目类别:
PDQ6: Loss of adiponectin as a contributing factor in cancer cachexia
PDQ6:脂联素丢失是癌症恶病质的一个促成因素
- 批准号:
8687301 - 财政年份:2014
- 资助金额:
$ 67.88万 - 项目类别:
Bioavailability and activity of dietary naringenin as a chemopreventive agent
膳食柚皮素作为化学预防剂的生物利用度和活性
- 批准号:
8401774 - 财政年份:2012
- 资助金额:
$ 67.88万 - 项目类别:
Bioavailability and activity of dietary naringenin as a chemopreventive agent
膳食柚皮素作为化学预防剂的生物利用度和活性
- 批准号:
8515361 - 财政年份:2012
- 资助金额:
$ 67.88万 - 项目类别:
Fatty acid supplementation in management of type 2 diabetes
补充脂肪酸治疗 2 型糖尿病
- 批准号:
7643913 - 财政年份:2007
- 资助金额:
$ 67.88万 - 项目类别:
MANAGEMENT OF TYPE 2 DIABETES MELLITUS BY CONJUGATED LINOLEIC ACID
通过共轭亚油酸治疗 2 型糖尿病
- 批准号:
7718621 - 财政年份:2007
- 资助金额:
$ 67.88万 - 项目类别:
Fatty acid supplementation in management of type 2 diabetes
补充脂肪酸治疗 2 型糖尿病
- 批准号:
7314641 - 财政年份:2007
- 资助金额:
$ 67.88万 - 项目类别:
Fatty acid supplementation in management of type 2 diabetes
补充脂肪酸治疗 2 型糖尿病
- 批准号:
7501506 - 财政年份:2007
- 资助金额:
$ 67.88万 - 项目类别:
MANAGEMENT OF TYPE 2 DIABETES MELLITUS BY CONJUGATED LINOLEIC ACID
通过共轭亚油酸治疗 2 型糖尿病
- 批准号:
7625441 - 财政年份:2007
- 资助金额:
$ 67.88万 - 项目类别:
Fatty acid supplementation in management of type 2 diabetes
补充脂肪酸治疗 2 型糖尿病
- 批准号:
7839925 - 财政年份:2007
- 资助金额:
$ 67.88万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:
- 批准年份:2021
- 资助金额:56 万元
- 项目类别:面上项目
成人与儿童结核病发展的综合研究:细菌菌株和周围微生物组的影响
- 批准号:81961138012
- 批准年份:2019
- 资助金额:100 万元
- 项目类别:国际(地区)合作与交流项目
统计学习影响成人汉语二语学习的认知神经机制
- 批准号:31900778
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Adenylate Kinase 2 Deficiency and the Failure of Myelopoiesis
腺苷酸激酶 2 缺乏和骨髓生成失败
- 批准号:
10906528 - 财政年份:2023
- 资助金额:
$ 67.88万 - 项目类别:
A novel mechanism of mitochondrial protein turnover in Complex I deficient mitochondrial cardiomyopathy
复合物 I 缺陷型线粒体心肌病中线粒体蛋白周转的新机制
- 批准号:
10537993 - 财政年份:2022
- 资助金额:
$ 67.88万 - 项目类别:
Adenylate Kinase 2 Deficiency and the Failure of Myelopoiesis
腺苷酸激酶 2 缺乏和骨髓生成失败
- 批准号:
10446518 - 财政年份:2022
- 资助金额:
$ 67.88万 - 项目类别:
Acylations: a novel pathway in the response to mitochondrial energy dysfunction
酰化:应对线粒体能量功能障碍的新途径
- 批准号:
10543478 - 财政年份:2022
- 资助金额:
$ 67.88万 - 项目类别:
A novel mechanism of mitochondrial protein turnover in Complex I deficient mitochondrial cardiomyopathy
复合物 I 缺陷型线粒体心肌病中线粒体蛋白周转的新机制
- 批准号:
10708844 - 财政年份:2022
- 资助金额:
$ 67.88万 - 项目类别: